We found a borderline significance of increased fractures reporting, without significant differences between age groups or products.
← all excerpts
The real-world safety profile of sodium-glucose co-transporter-2 inhibitors among older adults (≥ 75 years): a retrospective, pharmacovigilance study.
1
—
—